期刊
NATURE MICROBIOLOGY
卷 3, 期 3, 页码 295-301出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/s41564-017-0085-3
关键词
-
类别
资金
- Wellcome Trust [093008/Z/10/Z, WT104923/Z/14/Z]
- MRC [MR/L008246/1, MR/N020413/1]
- Medical Research Council [MR/P001424/1, MR/N020413/1] Funding Source: researchfish
- MRC [MR/P001424/1] Funding Source: UKRI
Only two trypanosome subspecies are able to cause human African trypanosomiasis. To establish an infection in human blood, they must overcome the innate immune system by resisting the toxic effects of trypanolytic factor 1 and trypanolytic factor 2 (refs. (1,2)). These lipoprotein complexes contain an active, pore-forming component, apolipoprotein L1 (ApoL1), that causes trypanosome cell death(3). One of the two human-infective subspecies, Trypanosoma brucei rhodesiense, differs from non-infective trypanosomes solely by the presence of the serum resistance-associated protein, which binds directly to ApoL1 and blocks its pore-forming capacity(3-5). Since this interaction is the single critical event that renders T. b. rhodesiense human-infective, detailed structural information that allows identification of binding determinants is crucial to understand immune escape by the parasite. Here, we present the structure of serum resistance-associated protein and reveal the adaptations that occurred as it diverged from other trypanosome surface molecules to neutralize ApoL1. We also present our mapping of residues important for ApoL1 binding, giving molecular insight into this interaction at the heart of human sleeping sickness.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据